• Company
• It surpassed ₩1 trillion in monthly drug imports
• by Kim, Jin-Gu Sep 23, 2021 05:43am

• Policy
• Price for Kymriah needs a new management method
• by Lee, Hye-Kyung Sep 23, 2021 05:43am

• Company
• The once-daily Xeljanz XR lands in general hospitals
• by Eo, Yun-Ho Sep 17, 2021 05:56am

• Policy
• Azelnidipine was approved in Korea
• by Lee, Tak-Sun Sep 17, 2021 05:56am

• InterView
• "A tenure professor’s calling is in developing a new drug"
• by Sep 17, 2021 05:56am

• Policy
• 58 companies agree on the redemption of α- GPC benefits
• by Lee, Hye-Kyung Sep 17, 2021 05:56am

• Company
• Blockbuster anticancer drug series 4 - Avastin
• by Sep 17, 2021 05:55am

• Company
• JAK inhibitors may fall to 2nd-line due to safety concerns
• by Nho, Byung Chul Sep 16, 2021 05:59am

• Company
• Nocdurna can be prescribed at general hospitals
• by Eo, Yun-Ho Sep 16, 2021 05:59am

• Policy
• Will Jeil Pharm gain a hold over the varenicline market?
• by Lee, Tak-Sun Sep 16, 2021 05:59am